FDA Approved Products

99 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:All NDA BLA ANDA

Lifecycle:Growth Peak LOE Approaching Post-LOE Launch Pre-Launch

Sort:Approval Date Name Competitive Pressure↓

Active:Lifecycle: LaunchClear all

ORAL · TABLET, EXTENDED RELEASE

Crinetics Pharmaceuticals

INTRAVENOUS · SOLUTION

SUBCUTANEOUS · SOLUTION

Arrowhead Pharmaceuticals

SUBCUTANEOUS · SOLUTION

ROCURONIUM BROMIDE

rocuronium bromide

INTRAVENOUS · SOLUTION

PTC Therapeutics

OWP Pharmaceuticals

ORAL · SUSPENSION

cyclobenzaprine hydrochloride

Tonix Pharmaceuticals

SUBLINGUAL · TABLET

OPHTHALMIC · SOLUTION/DROPS

proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progressiongenerally a urine protein-to-creatinine ratio (UPCR) ≥ 1

LENZ Therapeutics

OPHTHALMIC · SOLUTION/DROPS

ORAL · SOLUTION

sildenafil citrate

diazoxide choline

Soleno Therapeutics

ORAL · TABLET, EXTENDED RELEASE

leucovorin calcium

INTRAMUSCULAR, INTRAVENOUS · SOLUTION

telmisartan, amlodipine and indapamide

INTRAVENOUS · SOLUTION

lenacapavir sodium

Gilead Sciences

SUBCUTANEOUS · SOLUTION

lenacapavir sodium

Gilead Sciences

INHALATION · POWDER

← PreviousPage 4 of 5Next →